Skittlez Indoor CBD Flower single bud
Skittlez Indoor CBD Flower two buds
Skittlez CBD Flower Analysis

Skittlez (Indoor) - CBD 18.4%

Skittlez is an indoor flower grown in Switzerland with 18.4% CBD, from this year's harvest. A sativa-dominant hybrid in a pretty light green, it wins you over with its intense scent and woody, sweet and hazelnut flavours.
Regular price 17,80 € Sale price instead of 22,00 €

Availability: In stock – Ships within 24h

8,90 €/g
Tax included. Shipping calculated at checkout.
En Stock !
Livré en France sous 2 à 3 jours
Vous n'êtes pas en France ?

Summary

Skittlez Indoor CBD Flower

  • Grown indoors in Switzerland
  • Fresh and very fragrant flowers (this year's harvest)
  • Sativa-dominant hybrid
  • Flavours: Woody, Sweet, Hazelnut
  • CBD 18.4%

See all products:

Details

Skittlez Indoor CBD Flower 18.4%

Skittlez CBD hemp flower, 100% natural, with a beautiful light green colour. It is also smooth and fruity, to please as many people as possible. What's more, it was grown in France.

The Skittlez CBD Flower is a hybrid cannabis variety, although the balance tips quite clearly towards the Sativas. This Skittlez CBD Cannabis Flower contains 18.4% CBD.

It has a very tasty sweet, fruity, hazelnut and slightly woody flavour.

Very pleasant smell, firm and compact buds, and carefully manicured.

Growing method
Organic indoor cultivation in France.

Species
Sativa-dominant hybrid.

Concentration
CBD: 18.4%
THC: 0.16%

Certification
This CBD Cannabis flower was grown in France and also certified by a GMP-accredited laboratory.

Legislation
100% legal product in the European Union. This Skittlez CBD Cannabis Flower is a hybrid derived from varieties authorised in the European catalogue.

*Non-contractual photos, taken by us, from the batch currently on sale*

Aromas

Skittlez Indoor CBD Flower 18.4%

  • Woody
  • Sweet
  • Hazelnut

Similar

Discover other Indoor CBD flowers:

Sources and references (4)

Official and scientific sources on the regulation, safety, composition and quality of this type of product. They are provided for information and are not health claims.

  1. MILDECA (2021). L'indispensable sur... le cannabidiol (CBD). MILDECA — drogues.gouv.fr. View the source
  2. MILDECA (2023). Le CBD. drogues.gouv.fr (Mission interministérielle de lutte contre les drogues et les conduites addictives). View the source
  3. Chevallier C, Charuel L, Richeval C, Chaouachi L, Del Valle L, Eiden C, Gaulier JM, Batisse A (CEIP-A Paris, Lyon, Montpellier ; CHU Lille) (2023). Cannabidiol : analyse de produits « CBD non pharmaceutiques » disponibles sur le marché en France. MILDECA — drogues.gouv.fr (rapport CEIP-A financé par la MILDECA). View the source
  4. Dryburgh LM, Bolan NS, Grof CPL, et al. (2018). Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects. British Journal of Clinical Pharmacology. View the source

Recently viewed